DURVALUMAB

Clinical trials for DURVALUMAB explained in plain language.

Never miss a new study

Get alerted when new DURVALUMAB trials appear

Sign up with your email to follow new studies for DURVALUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New combo therapy shows promise for aggressive lung cancer

Disease control Ongoing

This study tested whether adding low-dose radiotherapy to standard chemotherapy and an immunotherapy drug (durvalumab) could help people with extensive-stage small cell lung cancer live longer without the disease getting worse. The trial enrolled 30 adults with advanced lung canc…

Matched conditions: DURVALUMAB

Phase: PHASE2 • Sponsor: You Lu • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

DURVALUMAB

Get alerted when new DURVALUMAB trials appear

New combo therapy shows promise for aggressive lung cancer